Repro-Med Systems Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko purchased 128,175 shares of the company’s stock in a transaction dated Friday, November 10th. The shares were acquired at an average price of $0.66 per share, for a total transaction of $84,595.50. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website.

Repro-Med Systems Inc. (OTCMKTS:REPR) opened at $0.66 on Tuesday. Repro-Med Systems Inc. has a 12 month low of $0.34 and a 12 month high of $0.70. The stock has a market cap of $26.17, a price-to-earnings ratio of 69.00 and a beta of -0.55.

TRADEMARK VIOLATION WARNING: “Repro-Med Systems Inc. (REPR) Director Joseph M. Jr. Manko Buys 128,175 Shares” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/14/repro-med-systems-inc-repr-director-joseph-m-jr-manko-buys-128175-shares.html.

Repro-Med Systems Company Profile

REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator.

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Stock Ratings for Repro-Med Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems Inc. and related stocks with our FREE daily email newsletter.